Susan Desmond-Hellmann Chief Executive Officer, Bill & Melinda Gates Foundation John Craig Venter Founder, Chairman and Chief Executive Officer, J. Craig Venter Institute Anthony S. Fauci Director, US National Institute of Allergy and Infectious Diseases (NIAID) Robin Robinson Retired Steve Davis President and Chief Executive Officer, PATH; Lecturer on Social Innovation, Stanford Graduate School of Business Ségolène Aymé Emeritus Director of Research, French Institute of Health and Medical Research (INSERM) Catherine Tuleu Reader, University College London School of Pharmacy Dalvir Gill Chief Executive Officer and Member of the Board of Directors, TransCelerate BioPharma Elisa Cascade President of Data Solutions, DrugDev Sir Andrew Dillon Chief Executive, UK National Institute for Health and Care Excellence (NICE) Catherine Bollard President, International Society of Cellular Therapy, and Professor of Paediatrics, Children’s National Medical Centre Passion Thomas Cech Distinguished Professor, University of Colorado Boulder Francis S. Collins Director, US National Institutes of Health Leroy (Lee) Cronin Regius Chair of Chemistry, University of Glasgow Julie Louise Gerberding Executive Vice President & Chief Patient Officer, Strategic Communications, Global Public Policy, & Population Health, Merck Sharp & Dohme Ben Goldacre Founder, AllTrails; Senior Clinical Research Fellow, Nuffield Department of Primary Care Health Sciences Andrew Lees Founder and Scientific Director, Fina Biosolutions LLC; Associate Professor of Medicine, University of Maryland School of Medicine, Center for Vaccine Development Edison T. Liu President and Chief Executive Officer, The Jackson Laboratory Brian Overstreet Co-Founder and President, Advera Health Analytics Mark Paxton Chief Executive Officer, Rx-360 Mike Rea Chief Executive Officer, IDEA Pharma Tomasz Sablinski Chief Executive Officer and Co-founder, Transparency Life Sciences Ros Smyth Director, UCL Great Ormond Street Institute of Child Health Matthew Todd Associate Professor, The University of Sydney, Australia; Founder, Open Source Malaria Stephen J Ubl President and Chief Executive Officer, PhRMA
